c-Maf suppresses human T-cell leukemia virus type 1 Tax by competing for CREB-binding protein

Cancer Science

Volumn 102, Issue 4, 2011, Pages 890-894

  Hieshima, Kunio ^a   Nagakubo, Daisuke ^a,f   Shigeta, Akiko ^a   Tanaka, Yuetsu ^b   Hoshino, Hiroo ^c   Tsukasaki, Kunihiro ^d   Yamada, Yasuaki ^e   Yoshie, Osamu ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

^e NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^f MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; TAX PROTEIN; TRANSCRIPTION FACTOR C MAF;

ARTICLE; BINDING COMPETITION; CD4+ T LYMPHOCYTE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION; VIRUS ENVELOPE;

BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CELL TRANSFORMATION, VIRAL; CREB-BINDING PROTEIN; GENE PRODUCTS, ENV; GENE PRODUCTS, TAX; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JURKAT CELLS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; LUCIFERASES; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MAF; RECEPTORS, CCR4; RETROVIRIDAE PROTEINS, ONCOGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TH2 CELLS; TRANSCRIPTIONAL ACTIVATION; VIRION;

EID: 79952773529     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01873.x     Document Type: Article

References (34)

1. Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 2007; 7: 270-80.
2. Hanon E, Stinchcombe JC, Saito M et al. Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity 2000; 13: 657-64.
3. Miyazato P, Yasunaga J, Taniguchi Y, Koyanagi Y, Mitsuya H, Matsuoka M. De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice. J Virol 2006; 80: 10683-91.
4. Yoshie O, Fujisawa R, Nakayama T et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood 2002; 99: 1505-11.
5. Chen S, Ishii N, Ine S et al. Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells. Int Immunol 2006; 18: 269-77.
6. Matsubar Y, Hori T, Morita R, Sakaguchi S, Uchiyama T. Delineation of immunoregulatory properties of adult T-cell leukemia cells. Int J Hematol 2006; 84: 63-9.
7. Yoshie O. Expression of CCR4 in adult T-cell leukemia. Leuk Lymphoma 2005; 46: 185-90.
8. Journo C, Douceron E, Mahieux R. HTLV gene regulation: because size matters, transcription is not enough. Future Microbiol. 2009; 4: 425-40.
9. Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 2001; 19: 475-96.
10. Jacobson S, McFarlin DE, Robinson S et al. HTLV-I-specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-I-associated neurological disease. Ann Neurol 1992; 32: 651-7.
11. Kannagi M. Immunologic control of human T-cell leukemia virus type I and adult T-cell leukemia. Int J Hematol 2007; 86: 113-7.
12. Basbous J, Arpin C, Gaudray G, Piechaczyk M, Devaux C, Mesnard JM. The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J Biol Chem. 2003; 278: 43620-7.
13. Lemasson I, Lewis MR, Polakowski N et al. Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J Virol 2007; 81: 1543-53.
14. Ho IC, Hodge MR, Rooney JW, Glimcher LH. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 1996; 85: 973-83.
15. Barnes MJ, Powrie F. Hybrid Treg cells: steel frames and plastic exteriors. Nat Immunol 2009; 10: 563-4.
16. Murakami YI, Yatabe Y, Sakaguchi T et al. c-Maf expression in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 2007; 31: 1695-702.
17. Hieshima K, Nagakubo D, Nakayama T, Shirakawa AK, Jin Z, Yoshie O. Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells. J Immunol 2008; 180: 931-9.
18. Hanon E, Hall S, Taylor GP et al. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 2000; 95: 1386-92.
19. Imai T, Nagira M, Takagi S et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999; 11: 81-8.
20. Hieshima K, Kawasaki Y, Hanamoto H et al. CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells. J Immunol 2004; 173: 3668-75.
21. Ohsugi T, Kumasaka T, Urano T. Construction of a full-length human T cell leukemia virus type I genome from MT-2 cells containing multiple defective proviruses using overlapping polymerase chain reaction. Anal Biochem 2004; 329: 281-8.
22. Haraguchi Y, Yang DW, Handa A, Shimizu N, Tanaka Y, Hoshino H. Detection of neutralizing antibodies against human T-cell leukemia virus type 1 using a cell-free infection system and polymerase chain reaction. Int J Cancer 1994; 59: 416-21.
23. Fujisawa J, Toita M, Yoshida M. A unique enhancer element for the trans activator (p40tax) of human T-cell leukemia virus type I that is distinct from cyclic AMP- and 12-O-tetradecanoylphorbol-13-acetate-responsive elements. J Virol 1989; 63: 3234-9.
24. Nakayama T, Hieshima K, Nagakubo D et al. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J Virol 2004; 78: 1665-74.
25. Moynagh PN. The NF-kappaB pathway. J Cell Sci 2005; 118: 4589-92.
26. Kashanchi F, Brady JN. Transcriptional and post-transcriptional gene regulation of HTLV-1. Oncogene 2005; 24: 5938-51.
27. Chen Q, Dowhan DH, Liang D, Moore DD, Overbeek PA. CREB-binding protein/p300 co-activation of crystallin gene expression. J Biol Chem. 2002; 277: 24081-9.
28. Goodman RH, Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev 2000; 14: 1553-77.
29. Colgin MA, Nyborg JK. The human T-cell leukemia virus type 1 oncoprotein Tax inhibits the transcriptional activity of c-Myb through competition for the CREB binding protein. J Virol 1998; 72: 9396-9.
30. Nicot C, Mahieux R, Pise-Masison C et al. Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-kappaB pathway and modulation of coactivator usage. Mol Cell Biol 2001; 21: 7391-402.
31. Harrod R, Kuo YL, Tang Y et al. p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/activator-enhancer complex. J Biol Chem. 2000; 275: 11852-7.
32. Tanaka Y, Hayashi M, Takagi S, Yoshie O. Differential transactivation of the intercellular adhesion molecule 1 gene promoter by Tax1 and Tax2 of human T-cell leukemia viruses. J Virol 1996; 70: 8508-17.
33. Hivin P, Gaudray G, Devaux C, Mesnard JM. Interaction between C/EBPbeta and Tax down-regulates human T-cell leukemia virus type I transcription. Virology 2004; 318: 556-65.
34. Bodor J, Spetz AL, Strominger JL, Habener JF. cAMP inducibility of transcriptional repressor ICER in developing and mature human T lymphocytes. Proc Natl Acad Sci U S A 1996; 93: 3536-41.